Artificial Intelligence in Cervical Cancer Research and Applications
Abstract:
Cervical cancer remains a leading cause of death among females, posing a severe threat to women's health. Due to the uneven distribution of resources in different regions, there are challenges regarding physicians' experience, quantity, and medical conditions. Early screening, diagnosis, and treatment of cervical cancer still face significant obstacles. In recent years, artificial intelligence (AI) has been increasingly applied to various diseases' screening, diagnosis, and treatment. Currently, AI has many research applications in cervical cancer screening, diagnosis, treatment, and prognosis, assisting doctors and clinical experts in decision-making, improving efficiency and accuracy. This study discusses the application of AI in cervical cancer screening, including HPV typing and detection, cervical cytology screening, and colposcopy screening, as well as AI in cervical cancer diagnosis and treatment, including magnetic resonance imaging (MRI) and computed tomography (CT). Finally, the study briefly describes the current challenges faced by AI applications in cervical cancer and proposes future research directions.
1. Introduction
Cervical cancer is one of the most common malignant tumors in women. On the basis of GLOBOCAN estimates for 185 countries in 2020, there were 604,000 new cases of cervical cancer and 342,000 deaths [1]. It is the only can through the efficient price of 9 human papilloma virus (HPV) vaccine, early detection and timely treatment to primary prevention strategies to eliminate cancer [2].
Nearly all cases of cervical cancer consist of 15 kinds of carcinogenic HPV genotypes caused by persistent infection. There are four main stages in the development of cervical cancer: metaplastic epithelial infection in the cervical transitional zone, persistent HPV infection, progression of persistently infected epithelium to precancerous lesions of the cervix, and infiltration of the epithelial basement membrane [3]. The HPV vaccine can protect age-appropriate females from HPV infection. However, even in some developed countries, the coverage rate of the HPV vaccine remains very low [2], [3], [4]. The slow progress of cervical lesion detection and treatment provides a number of very precious opportunities, such as, about 30% of all cervical intraepithelial neoplasia (CIN) level 3 lesions in 30 years progression to invasive cancer [5]. As screening techniques have improved, cancer detection rates have increased and death rates have declined. However, most deaths occur in low - and middle-income countries [6]. Despite advances in effective screening, diagnosis, and treatment programs, the accuracy and generalizability of screening, diagnosis, and treatment are relatively low due to the lack of physicians' experience, quantity, and medical conditions, posing significant challenges for early cervical cancer screening, diagnosis, and subsequent individualized treatment and prognosis. Therefore, it is crucial to develop a more accurate and cost-effective method for cervical cancer screening, diagnosis, and treatment.
In recent years, artificial intelligence (AI) is increasingly used in the diagnosis of various diseases, such as skin cancer classification [7], [8], retinal disease diagnosis and classification [9], and tumor imaging diagnosis [10], demonstrating good application value. In cervical cancer screening, diagnosis, and treatment, AI is also used to address the limited human resources and improve diagnostic accuracy. As described below, currently, AI has made many research achievements and progress in cervical cancer screening, including HPV typing and detection, cervical cytology screening, colposcopy screening, diagnosis, and treatment, including MRI and CT. This greatly improves the accuracy and specificity of cervical cancer screening, diagnosis, and treatment, assisting doctors and clinical experts in diagnosis and decision-making, contributing to overcoming the problems of inadequate accuracy and generalizability caused by the lack of physicians' experience, quantity, and medical conditions.
This study aims to introduce the latest artificial intelligence in cervical cancer research and applications, such as the integration of AI with HPV typing and detection, cervical cytology screening, colposcopy screening, cervical cancer lesion segmentation, and local staging in MRI, diagnosis of lymph node metastasis in cervical cancer, and diagnosis and treatment of cervical cancer in CT. This demonstrates the practicality, potential, and future challenges of AI in the early screening, diagnosis, and treatment of cervical cancer.
2. Artificial Intelligence in Cervical Cancer Screening, Diagnosis, and Treatment
Alan Turing first described the concept of simulating intelligent behavior and critical thinking in computers in 1950 [11]. In his book “Computing Machinery and Intelligence," he described a simple test to determine if a computer possesses human intelligence, which later became known as the “Turing Test" [12]. Six years later, John McCarthy defined Artificial Intelligence (AI) as the “science and engineering of making intelligent machines" [13], [14]. Over the following decades, the performance of artificial intelligence evolved into more complex algorithms resembling human-like capabilities. AI encompasses several subfields, such as Machine Learning (ML), Deep Learning (DL), and Computer Vision.
Machine learning refers to the analytical techniques which involved in technologies that learn patterns and derive criteria from data to predict and classify unknown objects based on these criteria [15]. ML is mainly divided into three types: Supervised learning, unsupervised learning, and reinforcement learning. Supervised learning is a kind of machine learning based on training data to provide the results or the answer, it is mainly used for regression and classification [16]. In supervised learning, training data is used as the known information for learning, building regression or classification models that can respond to unknown information. Representative techniques include decision tree-based methods, such as random forest methods and regression analysis. Unsupervised learning does not require training data to determine correct answers. It is used for grouping and summarizing data [17].
Deep Learning is a form of machine learning that drives the current AI boom, with over 90% being supervised learning [16], [17]. The neural network in deep learning consists of three types of layer categories: input layer, intermediate layer and output layer. It uses mathematical models to simulate neurons in human neural networks [15], [16]. The neural network's output is compared to the training data, adjusting the weights of the information to increase the accuracy of the output. The development and use of deep learning make anomaly detection, image processing, natural language processing and speech recognition possible [16], [17].
The relationship between artificial intelligence, machine learning, and deep learning is shown in Figure 1.

Artificial intelligence, particularly in the deep learning domain, has many applications in medicine, such as Automatic Visual Evaluation (AVE), automated dual-staining cytology, diagnostic radiology, and automated diabetic retinopathy screening [18], [19], [20]. Deep learning-based cervical image Automatic Visual Evaluation (AVE) is emerging as an alternative, low-cost solution for screening, diagnosis, and treatment [21]. Currently, AI is extensively applied in cervical cancer diagnosis and treatment, where machine learning SVM models and deep learning neural networks are rifely used in cervical cancer screening, including HPV typing and detection, cervical cytology screening, and colposcopy. AI is also used in cervical cancer diagnosis and treatment, including Magnetic Resonance Imaging (MRI) and computed tomography scans, as shown in Figure 2. However, there are still challenges, such as the scarcity of high-quality clinical data and the protection of patient data privacy. At the same time, there is a broader research prospect.

3. Artificial Intelligence in Early Screening of Cervical Cancer
Nearly all cervical cancers are caused by persistent infection with one of the high-risk HPV genotypes, of which there are 15 types in the cervical epithelium. The slow progress of cervical lesion detection and treatment provides a number of very precious opportunities. Therefore, early screening of cervical cancer is very important for the prevention, diagnosis, and early cure of cervical cancer. Related detection and diagnosis include HPV genotyping and testing, cervical cytology screening and colposcopy screening.
Based on deep learning, automatic visual assessment (AVE) of cervical images is becoming an alternative new low-cost screening and diagnostic solution. By leveraging big data and advanced computing resources, it provides accurate screening of cervical cancer and precancerous lesions. The following will specifically introduce three methods of early cervical cancer screening: HPV genotyping and testing, cervical cytology screening and colposcopy screening, as well as related research and progress of artificial intelligence technology in these methods. And discuss the potential benefits, limitations, and challenges of using artificial intelligence in cervical cancer screening, and future prospects and research directions.
Preliminary screening for cervical cancer in recent years, more and more dependent on the type of high-risk human papilloma virus (hrHPV), has been proved that the detection usually higher than cytologic examination has higher sensitivity and negative predictive value [22], [23].
ATHENA, a large trial has shown that patients infected with HPV16 or HPV18 which causes most cervical cancers are more likely to develop CIN3 or higher grade lesions [24], [25]. Therefore, if HPV testing is used as the primary screening tool for young women, those with HPV16 or HPV18 positivity should be promptly referred for the colposcopy, while for the patients with non-16 or 18 HPV, positivity cytological classification was further conducted [26]. Therefore, HPV genotyping is more conducive to cervical cancer screening and management. Many scholars are devoted to research related to AI and HPV testing. Deep learning methods such as CNN models and ANN models have achieved high accuracy on internal datasets of research units, reaching over 90%, showing a good application prospect of deep learning models in HPV detection, as shown in Table 1.
Author | Publication year | Method | Case load | Classification category | Bear fruit | Superiority |
Castro et al. [27] | 2019 | $\mathrm{CNN}$ | 96 People | Binary classification | Precision: $100 \%$ | Developed a digital-diffraction-based DNA detection method |
Miyagi et al. [28] | 2019 | $\mathrm{CNN}$ | 253 People | Binary classification | Accuracy: $94.1 \%$ sensitivity: $95.6 \%$ specificity: $83.3 \%$ | Exploring the feasibility of classifying cervical squamous epithelial disease using deep learning from colposcopy images in combination with HPV types |
Bogani et al. [29] | 2019 | ANN | 5104 People | - | The accuracy of the AI classifier and gynecological oncologists were 0.941 and 0.843 respectively. | Bogani et al. [29] studied whether the pretreatment human papillomavirus (HPV)genotype predicted the risk of persistence or recurrence of cervical dysplasia. Artificial neural network (ANN) analysis was used to assess the importance of different HPV genotypes in predicting the persistence and recurrence of cervical dysplasia. |
He et al. [30] | 2022 | 25971 People | - | - | To analyze the feasibility and application value of AI-assisted cervical cytology screening combined with human papillomavirus (HPV) shunt in free cervical cancer screening in rural women. The results showed that AI-assisted cytology and high-risk HPV shunt reduced the colposcopy referral rate and improved the diagnostic agreement rate between cytology and biopsy pathology. | To analyze the feasibility and application value of AI-assisted cervical cytology screening combined with human papillomavirus (HPV) shunt in free cervical cancer screening in rural women. The results showed that AI-assisted cytology and high-risk HPV shunt reduced the colposcopy referral rate and improved the diagnostic agreement rate between cytology and biopsy pathology. |
There are two methods of cervical cytology. The first is the traditional Pap smear, and the second is liquid-based cytology (LBC) [31], [32], [33], [34]. Over the past 60 years, the pap smear screening has had a significant effect on reducing cervical cancer mortality [35]. Due to cost issues, the most common method for diagnosing malignant cervical tumors is currently cervical cytology [36], [37]. These tests are carried out by specialist cytologists who analyse a sample of cervical cells taken from a patient's cervix under a microscope to detect the effects of HPV. However, because each slide contains about 3 million cells with different orientations and overlapping [38]. So manual screening is expensive, difficult, time consuming, expensive, and error-prone, because each slide contains about 3 million different oriented and overlapping cells [39], [40].
In medical image analysis, DL programs are now a repeating and successful type of machine learning algorithm. Cervical cytology image analysis is no exception. The popular deep architecture is convolutional neural network (CNN) is widely used in this field. This method has good results in cell detection, cell segmentation, cell classification, and cell region of interest (ROI) extraction [41].
The main goal of segmentation is to segment medical images into multiple regions for rapid analysis of cells [42]. Accurate segmentation of the cell nucleus and cytoplasm is critical because the cell nucleus carries reliable information for cancer detection. In the medical field, automatic segmentation saves patients' lives by providing fast, reliable and accurate disease diagnosis. Due to these advantages, many researchers are using deep learning (such as convolutional neural networks and feature attention networks) to perform segmentation tasks on cervical cells, with an accuracy and recall rate of over 90% on internal datasets. This demonstrates the good application prospects of deep learning models in cervical cell segmentation, which can greatly improve the screening efficiency of expert detection. Relevant research is shown in Table 2.
Author | Publication year | Method | Case load | Classification category | Bear fruit |
Song et al. [43] | 2019 | Adaptive shape priors extracted from cytoplasmic profile fragmentation and shape statistics to segment the overlapping cytoplasm of cells in the cervical smear image. | - | - | The experimental results show that the proposed method is general enough to be applied to other similar microscopy image segmentation tasks in the presence of a large number of overlapping objects. |
Wan et al. [44] | 2019 | TernausDetDee pLab V2 | ISBI2014 (945) ISBI2015 (210) Internal dataset (580) | ISBI2014: DCS 93% ISBI2015: DSC 92% Internal dataset: 92% | A new framework based on deep convolutional neural network (DCNN) is proposed for automatic segmentation of overlapping cells. |
Wang et al. [45] | 2021 | VGG16+SGD | Internal dataset (143) | Precision rate: 93% Recall: 90% | The proposed method handles the whole Pap smear for only 210 seconds, which is 20 times faster than U-Net and 19 times faster than SegNet. |
Zhao et al. [46] | 2022 | LEANE | Herlex Dataset (917) WBC Dataset (400) Warwick-QU dataset (165) | Precision: 93.01% Recall: 96.1% | A lightweight feature attention network (LEANet) is proposed to accurately segment the nucleus and cytoplasm regions in cervical images. |
Image classification is a major area of research in medical image analysis. It is a process in computer vision. In this field, deep learning-based methods have made enormous contributions by providing the most advanced accuracy [47]. Computer vision is also an indispensable part of cervical cell classification. A large number of studies have shown that cervical cells can achieve an accuracy of 95% or more in binary classification and multi-classification tasks on homemade datasets and public datasets, providing an effective tool for cervical cancer classification in clinical settings. Relevant research is shown in Table 3.
Author | Publication Method year | Data set | Classification category | Bear fruit | Superiority | |||
Wang et al. [48] | 2020 | BsiNet-TAP | Self-made data set (389) | Three classification | Precision: 98.49% | An adaptive pruning deep transfer leaming model is proposed for Pap smear image classification. | ||
Huang et al. [49] | 2020 | LASSO+ EL-SVM | Self-made data set (468) | Seven classification | Nomal accuracy: 99.64%, HSIL accuracy: 87.4%, LSIL accuracy: 91.88%, Cancer accuracy: 81.4% | We propose a cervical biopsy tissue image classification method based on minimum absolute contraction and selection operator and integrated Learning-support vector machine. | ||
Dong et al. [50] | 2020 | Inception v3 | Herlex data set (917) | Binary classification | Accuracy: 98.23%, Sensitivity: 99.44%, Specific: 96.73% | To propose a cell classification algorithm combining Inception v3 and artificial features. | ||
Dong et al. [51] | 2021 | PSO-SVM | Herlex data set (917) | Seven classification | Accuracy: 99.81% Sensitivity: 99.89% Recall: 99.26% | We propose a machine learning method for cervical cell classification based on a feature selection algorithm. | ||
Liu et al. [52] | 2021 | LSPS-net | Self-made data (2119) | Two categories and three categories | Accuracy of three classification: 90.90% | Developed an LSPS net integrated 2 D light-scattering static flow cytometer for single-cervical cell analysis. | ||
Rahaman et al. [53] | 2021 | DeepCervix | SIPakded Se Data Set (4049) Herlex Data set (917) | STAaldyed Data set: two classifichtion; three classification; five classification Herlex data set: two classification; seven classification | SIPalbyeD accuracy on the data set: 2: 99.85% 3.99.38% 7.99.14% Herlev accuracy on the data set: 2 classification: 98.32% 7: 90.32% | A DeepCerrix algorithm based on DL hybrid depth feature fusion (HDFF) technology is proposed. | ||
Chen et al. [54] | 2022 | HI+Ghostnet | SIPakkMeD data set (4049) | Five classification | Accuracy: 96.39%, Sensitivity: 96.42 %, Specific: 99.09 %, Recall: 96.39% | Proposed a hybrid loss function HL with label smoothing | ||
Cho et al. [55] | 2022 | DenseNet- 161Effic ientNet-B7 | Self-made data set (1106) | Three classification | DenseNet-161 Accuracy: 91.4% EfficientNet-B7 Accuracy: 92.6% | The performance of two pre-trained convolutional neural network (CNN) models using the DenseNet-16 and EfficientNet-B7 architectures was evaluated. | ||
Kanavati et al. [56] | 2022 | CNN+RNN | Self-made data set (1468) | Binary classification | Accuracy: 90.7%, Sensitivity: 85%, Specific: 91.1% | A dataset of 1,605 cervical WSI was used. We evaluated the model on three test sets, with ROC AUC in the range 0.89-0.96. | ||
Yaman and Tuncer [57] | 2022 | DarkHet | STPAWWeD Data Set Mendeley Data Set (4049) | Five classification | SIPaKMGD, Accuracy of data set: 95.43% Accuracy of Mendeley data set: 99.23% | A cervical cancer detection method based on the typical pyramid deep feature extraction has been proposed. |
Colposcopy involves magnifying a fully exposed cervix 5 to 40 times using the specific instruments used for this examination to visually assess the cervix in real time, especially the transformation zone, to detect cervical intraepithelial neoplasia (CIN) or squamous intraepithelial lesion (SIL) and invasive cancer [58]. Comprehensive colposcopy should include visibility of the cervix, visibility of the squamous columnar junction, presence or absence of acetic acid whitening, presence or absence of lesions, visibility of lesions, size and location of lesions, changes in blood vessels, other characteristics of lesions, and colposcopic impression [59].
Automatic segmentation of acetic acid lesions in colposcopy images is critical for assisting gynecologists in grading cervical intraepithelial neoplasia and cervical cancer [60]. Relevant research on colposcopy image segmentation using deep learning is currently relatively weak compared to research on colposcopy image classification, but existing relevant research has shown considerable results [61], [62]. Existing research shows high accuracy and specificity on homemade and public datasets, which can assist experts in improving detection and screening efficiency and accuracy [63], [64]. Relevant research results are shown in Table 4.
Author | Publication year | Method | Data set | Bear fruit | Superiority |
Yuan et al. [65] | 2020 | U-Net | Self-made data set (22330) | Average accuracy of acetic acid image: 95.59%, accuracy of iodine image: 95.70% | An independent dataset of HD images was collected and, in addition, a comparison of diagnostic accuracy between the colposcopist and the model. |
Guo et al. [66] | 2020 | Mask R-CNNMaskX R-CNN | CVT (Costa Rica Vaccine Trial) dataset (3398); ALTS dataset (939); MobileQDT. dataset (1960) | Dice:0.9471oU: 0.901 | Two state-of-the-art deep learning-based object localization and segmentation methods, the Mask R Convolutional Neural Network (CNN) and MaskX R-CNN, were evaluated for automated cervical segmentation using three datasets. |
Yue et al. [67] | 2021 | AWL-CNN | Self-made data set (3045) | Dice: 0.823 $\pm$ 0.129; Precision: 0.928 $\pm$ 0.139 | A novel AW, lesion-sensing convolutional Neural Network (AWLCNN), for the segmentation of AW lesions in cervical maps, is presented. |
Liu et al. [68] | 2022 | DeepLab V3+ | Self-made data set (280) | Average specificity was 94.9%; average accuracy 91.2%; and average sensitivity 78.2% | The cervical region was first extracted from the original colposcopy images by the k-means clustering algorithm. The AW region was again segmented from the neck region with DeepLabV3 +. |
Colposcopy is easy to misdiagnose and miss diagnosis because of its poor consistency with pathology. In addition, colposcopy performed by an inexperienced clinician can lead to potential harm (including vaginal discharge, pain or even bleeding, infection, etc.), so the doctor needs adequate training to achieve a certain level of proficiency to be competent. However, the long training time of the relevant doctors and the lack of qualified or skilled personnel pose a great challenge to the application of colposcopy diagnosis. In the past, deep learning has been widely and effectively applied in medical imaging. Therefore, deep learning technology can be applied in colposcopy classification tasks, which helps to solve the bottleneck and problems of traditional colposcopy, thus significantly improving its diagnostic performance. At present, there are also many research results showing that deep learning has achieved good results in classifying colposcopy images on homemade and public datasets, which can greatly improve the classification and diagnosis efficiency of doctors and experts. Relevant research is shown in Table 5.
Author | Publication year | Method | Data set | Classification category | Bear fruit | Superiority |
Kudva et al. [69] | 2019 | AlexNet;VGG-16 | IEEE Dataport cervigram (3339) | Two categories and four categories | Accuracy of two classification: 91.66%, Accuracy of four classification: 83.33% | Proposed as a novel hybrid transfer learning technique |
Buiu et al. [70] | 2020 | MobileNetV2 | 253 People | Binary classification | Accuracy: 94.1%, sensitivity: 95.6%. specificity: 83.3% | In this paper, we propose an automated colposcopy image analysis framework based on an ensemble of MobileNetV2 networks. |
Saini et al. [71] | 2020 | ColpoNet | Self-made data set (400) | Three classification | Precision:81.353% | Proposed a deep learning based ColpoNet network using colposcopy images for cervical cancer classification |
Luo et al. [72] | 2020 | DenseNet121 ResNet50 | homemade data set (3920) | Four classification | Accuracy: 79% Sensitive: 70.4% Specificity: 82.2% | A multiple CNN (DenseNet121 ResNet50) decision feature integrated system MDFI for diagnosis of cervical precancerous is proposed. |
Yu et al. [73] | 2021 | C-GCNN | Homemade dataset MSCI (679) | Four classification | Accuracy: 96.87% Sensitivity: 95.68% Specificity: 98.72%. | A multistate Colposcopy Image dataset (MSCI) is presented. Establish a CIN hierarchical model C-GCNN based on the MSCI dataset. |
Adweb et al. [74] | 2021 | PreLU-ResNet | Datasets in Intel and MobileODT cervical cancer screening | Three classification | Accuracy: 100% Sensitive: 97.8% Specificity: 98.1% | Three residual networks of the same structure were constructed using different activation functions. |
Park et al. [75] | 2021 | ResNet-50; XGB; SVM; RF | Self-made data set (4119) | Binary classification | Accuracy: ResNet-50:91% XGB: 74% SVM: 76%RF: 71% | The performance of two different models, machine learning and deep learning, are compared. |
Liu et al. [76] | 2021 | ResNet | Self-made data set (15276) | Binary classification | NC and LSIL + Classification: Accuracy: 88.6% Sensitivity: 93.2% Specificity: 84.6% HSIL-and HSIL + Classification: Accuracy: 80.7% Sensitivity: 82.3% Specificity: 80% | The residual neural network (ResNet) was calculated for each patient. And the results were compared with the diagnosis of a senior colposcoscopist and a junior colposcopist. |
Artificial intelligence in early cervical cancer screening, including HPV genotyping and testing, cervical cytology screening and colposcopy screening, has achieved good research results and has good application prospects. It can greatly improve the screening efficiency and accuracy of doctors and experts. It helps to solve problems such as missed diagnosis and misdiagnosis caused by insufficient experience, quantity and medical conditions of physicians. However, the clinical data currently available is generally of poor quality. At the same time, privacy issues such as the protection of patient data also need to be considered. In the future, improving the quality of clinical image data can further improve the accuracy and applicability of artificial intelligence technology in early cervical cancer screening. It has good research prospects and is expected to further improve the popularity and diagnostic accuracy of early cervical cancer screening, especially in underdeveloped regions.
4. Artificial Intelligence in the Diagnosis and Treatment of Cervical Cancer
Cross-sectional imaging modalities generally include computed tomography (CT), magnetic resonance imaging (MRI) and positron emission tomography (PET-CT). It is an important tool for studying prognostic factors of cervical cancer, such as lymph node status, parametrial invasion, cervical canal extension, tumor size, pelvic sidewall, tumor size and so on. Imaging indications also include cervical cancer follow-up, assessment of tumor response to treatment, and selection of appropriate candidates for less radical surgery, such as radical cervical excision to preserve fertility. MRI is the preferred imaging method for local cervical cancer assessment, while CT is also effective for assessing extrauterine spread of the disease [77].
However, at present, due to the lack of experience, quantity and medical conditions of physicians, the accuracy and generalization of existing diagnosis and treatment are relatively low. Therefore, early screening, diagnosis and subsequent individualized treatment and prognosis judgment of cervical cancer still face enormous challenges. This paper will mainly introduce the application of artificial intelligence in the diagnosis and treatment of cervical cancer on magnetic resonance imaging (MRI) images, including cervical cancer lesion segmentation and local staging, and diagnosis of cervical cancer lymph node metastasis (LNM) on MRI, as well as applications on computed tomography (CT) images in the diagnosis and treatment of cervical cancer.
MRI has been shown to be highly accurate in preoperative staging of cervical cancer [78], [79]. Therefore, MRI is the preferred method for local staging, treatment response evaluation, tumor recurrence detection and follow-up of cervical cancer patients [80]. The main purpose of MRI is to determine the presence of tumor surrounding infiltration and lymph node metastasis (LNM) [81].
MRI has higher soft tissue resolution than CT. It can determine tumor size and adjacent pelvic structures, and assess invasion around the uterus and involvement of uterus and vagina [82]. SVM model, U-Net model, 3D-CNN model, CapsNet model, etc. The accuracy on self-built datasets can reach more than 90%. Related research is shown in Table 6.
Author | Publication year | Learning goals | Data set | Method | Bear fruit |
Wang et al. [83] | 2020 | Partition: the prediction of parauterine invasion | There were 137 patients. | SVM model | Training Set AUC T2WI: 0.797 T 2 WI and DWI 0.780 (95% CI) Validation Set T2WI 0.946 (95% CI) T 2 WI and DWI 0.921 (95% CI) |
Lin et al. [84] | 2020 | To evaluate the performance of U-Net in fully automated localization and segmentation of cervical tumors in magnetic resonance (MR) images | There were 169 patients. | U-Net model | Dice coefficient: 82% Sensitivity: 89% Positive prediction: 92% |
Wang et al. [85] | 2021 | Identification and segmentation of cervical cancer lesions | TThere were 80 patients. | 3D-CNN model | Precision:93.11% |
Cibi et al. [86] | 2022 | Local staging of the cervical cancer | The 12,771 pieces of Fig | CapsNet model | Precision:90.28% |
Yan et al. [87] | 2019 | Assisted in the diagnosis of lymph node metastasis | There were 153 patents. | Radiomics model | Accuracy: 78.4% Sensitive: 86.7% Specificity: 75% |
Wang et al. [88] | 2019 | Assisted in the diagnosis of lymph node metastasis | There were 96 patients. | SVM model | C-index: 0.922 (P=3.412*10-2 |
Wu et al. [89] | 2020 | Assisted in the diagnosis of lymph node metastasis | There were 479 patients. | DL model | AUC 0.933 (95% CI) |
It helps early diagnosis of cervical cancer LNM. Although CT and MRI have an accuracy of only 83% to 85% in assessing lymph node involvement, but they are particularly high specificity, can even reach to 93% from 66% [90]. In 2018, the cervical cancer staging system was revised, and lymph node status was included as a staging criterion for the first time. Imaging or pathology showing lymph node involvement in cervical cancer is classified as stage IIIC [91]. Radiology has now advanced to the point where it can bridge the gap between fusion imaging and precision medicine. Radiology extracts the wealth of information hidden in medical images by combining the use of statistical analysis with sophisticated image analysis tools [92]. Many scholars have achieved good accuracy using radiogenomics models, SVM models, DL models, etc. on self-built datasets. Related research is shown in Table 6.
Accurate detection of cervical cancer plays a crucial role in disease treatment and prognosis prediction, so the accuracy and timeliness of detection are very important [93]. Computed tomography (PET/CT) and fluorodeoxyglucose positron emission tomography (FDG-PET/CT) play an important role in cervical cancer detection because of their superior sensitivity and specificity [94]. However, traditional FDG-PET/CT data analysis takes an especially long time and is not efficient because it requires interpretation of hundreds of images for each patient. However, with the development of computer hardware and algorithm and progress, especially in machine learning, especially on behalf of the development of deep learning [95], image processing techniques [96] play an indispensable role in many fields of clinical medicine [97]. The application of this technology in the diagnosis of cervical cancer can help clinicians make judgements, reduce workload and improve diagnostic accuracy [98]. Many scholars have achieved high accuracy using CNN, DpnUNet, YoloV5 and other deep learning models on self-built datasets. Related research is shown in Table 7.
Author | Publication year | Learning goals | Case load | Method | Bear fruit |
Shen et al. [99] | 2019 | To achieve early prediction of local and distant failure in patients with locally advanced cervical cancer. | 142 | CNN | Tumor prediction: sensitivity 71%, and specificity 93%; distant metastasis: sensitivity 77% and specificity 90% |
Liu et al. [100] | 2021 | To realize automatic segmentation of clinical target volume contour of cervical cancer. | CT:237 | DpnUNet | Dice similarity coefficient (DSC): 0.88; 95th percentile Hausdorff distance (95HD)3.46mm |
Ming et al. [101] | 2022 | Image registration, multimodal image fusion, and detection of lesion objects. | CT/PET:220 | YoloV5 | Meverage accuracy above the joint threshold (AP50): 84.3 |
Artificial intelligence has been extensively studied and applied in the diagnosis and treatment of cervical cancer. It has achieved good results in cervical cancer lesion segmentation and local staging on MRI, early diagnosis of cervical cancer LNM, and computed tomography, greatly improving the accuracy and specificity of early prediction and diagnosis, improving the efficiency of cervical cancer diagnosis and treatment, helping clinicians make decisions, reducing the workload of physicians and reducing misdiagnosis rates. However, there are still problems such as lack of high-quality clinical data, reliability and stability of models need to be improved. At the same time, issues such as patient data protection and security also need to be considered. Currently, there is less research on the treatment and prognosis prediction of cervical cancer using artificial intelligence, with greater challenges and research prospects.
5. Conclusions
In summary, artificial intelligence has performed well in computer vision and imaging, especially in the medical field, helping clinicians make decisions, reducing the workload of physicians and reducing misdiagnosis rates. Artificial intelligence has achieved good results in early screening, diagnosis and treatment of cervical cancer, and prognosis prediction, improving the specificity and accuracy of screening and diagnosis, and has good applicability. Overall, while improving the specificity and accuracy of screening and diagnosis, it has overcome a series of problems such as time constraints, limited specialists and subjective bias caused by physicians, which will enable cervical cancer screening to be implemented in resource-poor areas, thereby significantly reducing the incidence of cervical cancer.
However, the application of artificial intelligence currently still faces a series of problems such as lack of high-quality clinical data, obstacles in the management of medical data, lack of technical maintenance, reliability and stability of models need to be improved, and models have not yet been promoted in clinical applications. At the same time, the use of artificial intelligence in cervical cancer screening and diagnosis will also involve ethical and privacy issues, such as the protection and security of patient data.
Artificial intelligence has a promising application prospect in cervical cancer screening, especially in cervical cytology screening, where the application of convolutional neural networks (CNN) has been relatively mature. CNN has achieved great success in cell detection, segmentation, classification and region of interest (ROI) extraction [34]. The assistance of related models can greatly improve the detection efficiency of cervical cytology experts. However, segmentation techniques still face many challenges, which may be the direction of future development. Effective segmentation techniques can further improve the accuracy and reliability of artificial intelligence in cervical cancer screening and diagnosis. In addition to early screening and diagnosis, artificial intelligence can also be applied to treatment, prognosis prediction and prevention of cervical cancer, which will also be an important research direction in the future with good application prospects. It is believed that in the future, artificial intelligence will greatly improve the predictive ability of cervical cancer, maximize the improvement of cervical cancer screening and diagnosis, optimize the staging system, improve patient prognosis, and be fully applied to the early diagnosis, treatment and prognosis prediction of cervical cancer.
Not applicable.
The authors declare no conflict of interest.
